Skip to main content
ProGen, Co,, LTD. logo

ProGen, Co,, LTD. — Investor Relations & Filings

Ticker · 296160 ISIN · KR7296160005 KO Manufacturing
Open in API
Filings indexed 153 across all filing types
Latest filing 2024-08-06 M&A Activity
Country KR South Korea
Listing KO 296160

About ProGen, Co,, LTD.

https://progen.co.kr

ProGen is an R&D-focused biopharmaceutical company dedicated to developing innovative drugs for incurable diseases, with a primary focus on oncology, immune diseases, and metabolic disorders. The company specializes in creating novel protein-based immunotherapies and antibody therapeutics. Its research and development efforts are driven by proprietary technology platforms, including the NTIG (Neo Tri-ImmunoGlobulin) platform for next-generation multi-specific fusion proteins and the hyFc® platform for long-acting fusion proteins. These technologies enable the engineering of advanced bi-specific and multi-specific therapies designed to address significant unmet medical needs.

Recent filings

Filing Released Lang Actions
주요사항보고서(타법인주식및출자증권양도결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange regarding the decision to sell shares in another company (Progen's sale of Hansome Life & Co. shares). This type of regulatory filing, which details specific corporate transactions like asset disposals or share transfers, falls under the category of general regulatory announcements for material events.
2024-08-06 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a Korean company (Progen) detailing the acquisition of its own convertible bonds before maturity. This type of corporate action, involving the repurchase of debt instruments, falls under capital structure changes and financing updates. Given the specific nature of the transaction (repurchase of convertible bonds), it is best classified as a Capital/Financing Update.
2024-08-06 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically marked as a '정정신고' (Amendment Report). It details changes to the number of stock options granted due to employee turnover. This type of disclosure regarding stock option grants and their subsequent amendments is a standard regulatory requirement for listed companies in Korea, falling under the category of general regulatory announcements.
2024-07-01 Korean
기업설명회(IR)개최결과
Regulatory Filings Classification · 100% confidence The document is a formal notification regarding the results of an Investor Relations (IR) meeting held by the company ProGen. It details the date, location, attendees, and agenda of the meeting. Since it is a short regulatory announcement confirming that an IR event took place and where the materials can be found, it falls under the category of a regulatory filing announcement.
2024-06-11 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, time, location, target audience, and agenda for the meeting. Since this is an announcement of an event rather than the presentation slides themselves, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it is classified as a Regulatory Filing (RNS) as it serves as a general corporate disclosure of an event.
2024-06-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (증권선물위원회) and the Korea Exchange. This is a standard regulatory filing in South Korea used to disclose insider shareholdings and changes in ownership by company executives. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS), which covers reports of personal share transactions and ownership status by company directors and executives.
2024-04-11 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.